Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Pulmonx
LUNG
$92.8M
| $701K | ﹤0.01% |
104,205
+37,694
| +57% | +$267K |
|
3252
iShares MSCI Switzerland ETF
EWL
$2.22B
| $700K | ﹤0.01% |
13,524
-90,724
| -87% | -$4.58M |
|
3253
Green Plains
GPRE
$1.09B
| $700K | ﹤0.01% |
144,405
+9,604
| +7% | +$68.8K |
|
|
DFTX
3254
Definium Therapeutics
DFTX
$5.9B
| $700K | ﹤0.01% |
119,573
-35,861
| -23% | -$257K |
|
|
OPTU
3255
Optimum Communications Inc
OPTU
$228M
| $697K | ﹤0.01% |
261,989
-1,722,194
| -87% | -$4.65M |
|
3256
i3 Verticals
IIIV
$325M
| $697K | ﹤0.01% |
28,240
-11,593
| -29% | -$294K |
|
3257
Arhaus
ARHS
$1.37B
| $696K | ﹤0.01% |
80,056
-30,391
| -28% | -$325K |
|
3258
Daily Journal
DJCO
$828M
| $695K | ﹤0.01% |
1,748
-697
| -29% | -$301K |
|
3259
Titan International
TWI
$438M
| $695K | ﹤0.01% |
82,790
-25,090
| -23% | -$207K |
|
3260
Weave Communications
WEAV
$426M
| $694K | ﹤0.01% |
62,589
-139,085
| -69% | -$2M |
|
3261
Frontier Group Holdings
ULCC
$1.57B
| $693K | ﹤0.01% |
159,572
+77,862
| +95% | +$580K |
|
3262
Great Southern Bancorp
GSBC
$888M
| $692K | ﹤0.01% |
12,504
-3,920
| -24% | -$229K |
|
3263
International Money Express
IMXI
$353M
| $692K | ﹤0.01% |
54,841
-16,163
| -23% | -$277K |
|
3264
PUT
Cigna
CI
$73.5B
| $691K | ﹤0.01% |
2,100
+2,000
| +2,000% | +$603K |
|
|
GRAL
3265
GRAIL Inc
GRAL
$3.05B
| $690K | ﹤0.01% |
26,999
+2,892
| +12% | +$89.4K |
|
3266
Luxfer Holdings
LXFR
$457M
| $689K | ﹤0.01% |
58,096
-14,692
| -20% | -$192K |
|
3267
ATN International
ATNI
$491M
| $687K | ﹤0.01% |
33,849
-5,149
| -13% | -$92.3K |
|
3268
Alerus Financial
ALRS
$844M
| $685K | ﹤0.01% |
37,082
-10,919
| -23% | -$217K |
|
3269
Chemung Financial Corp
CHMG
$403M
| $682K | ﹤0.01% |
14,344
+3,210
| +29% | +$157K |
|
3270
Compass Minerals
CMP
$1.1B
| $682K | ﹤0.01% |
73,423
-5,042
| -6% | -$57.6K |
|
|
DCH
3271
Dauch Corp
DCH
$1.6B
| $680K | ﹤0.01% |
167,065
-84,834
| -34% | -$435K |
|
3272
National Presto Industries
NPK
$987M
| $678K | ﹤0.01% |
7,714
-2,491
| -24% | -$237K |
|
3273
Vanguard FTSE All-World ex-US ETF
VEU
$70.6B
| $675K | ﹤0.01% |
11,135
| – | – |
|
3274
Gray Television
GTN
$520M
| $675K | ﹤0.01% |
156,297
-142,189
| -48% | -$559K |
|
|
MRX
3275
Marex Group Limited Ordinary Shares
MRX
$5.2B
| $675K | ﹤0.01% |
+19,107
| New | +$665K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.